+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

No interplay between the pathways mediating coagulation and inflammation in tissue factor-induced disseminated intravascular coagulation in rats



No interplay between the pathways mediating coagulation and inflammation in tissue factor-induced disseminated intravascular coagulation in rats



Critical Care Medicine 34(10): 2646-2650



Previous reports have suggested an interplay between the pathways mediating coagulation and inflammation in endotoxemia and sepsis. The present study was designed to examine whether cross-signaling between the pathways mediating coagulation and inflammation occurs, as suggested by the pattern of cytokine production observed following tissue-factor (TF)-induced disseminated intravascular coagulation (DIC). Prospective, comparative, experimental study. Laboratory at a university hospital. Male Wistar rats, aged 6-7 wks, and weighing 160-170 g. Male Wistar rats were administered TF (3.75 units/kg every 4 hrs), TF, and tranexamic acid (TA; 50 mg/kg every 4.5 hrs) or lipopolysaccharide (30 mg/kg every 4 hrs) via the tail vein, and blood was sampled at 0, 4, 8 and 12 hrs. Subsequent alterations in thrombin-antithrombin complex and fibrinogen levels, as well as platelet counts, indicated that the severity of both types of experimental DIC (TF-induced and lipopolysaccharide-induced) was similar with respect to hemostatic activation and development of consumption coagulopathy. In lipopolysaccharide-induced DIC, a sharp increase in plasma tumor necrosis factor levels was observed at 4 hrs, after which a sharp decline was noted. Plasma levels of interleukin-6 were markedly increased at 4 hrs, after which a sustained elevation was observed for the duration of the experimental period (tumor necrosis factor, 1270 +/- 280, 180 +/- 40, and 120 +/- 30 pg/mL at 4, 8 and 12 hrs, respectively; interleukin-6, 5810 +/- 1320, 4850 +/- 730, and 5230 +/- 1280 pg/mL at 4, 8 and 12 hrs, respectively). On the other hand, tumor necrosis factor and interleukin-6 were not detected following TF-induced DIC (0 +/- 0 at 4, 8, and 12 hrs for both tumor necrosis factor and interleukin-6). In the TF+TA group, significant increases in tumor necrosis factor and interleukin-6 were observed, compared with the TF group. There is no overt interplay between the pathways mediating coagulation and inflammation in TF-induced DIC, as observed in lipopolysaccharide-induced DIC.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 049699332

Download citation: RISBibTeXText

PMID: 16932226

DOI: 10.1097/01.ccm.0000240228.43264.66


Related references

Monoclonal antibody specific for tissue factor pathway inhibitor-factor Xa complex: its characterization and application to plasmas from patients with disseminated intravascular coagulation and pre-disseminated intravascular coagulation. Blood Coagulation and Fibrinolysis 10(6): 309-319, 1999

Expression of tissue factor and tissue factor pathway inhibitor in rats lungs with lipopolysaccharide-induced disseminated intravascular coagulation. Laboratory Investigation; a Journal of Technical Methods and Pathology 77(6): 581-589, 1997

Pathophysiology of disseminated intravascular coagulation progresses at a different rate in tissue factor-induced and lipopolysaccharide-induced DIC models in rats. Blood Coagulation & Fibrinolysis 14(3): 221-228, 2003

Pathophysiology of disseminated intravascular coagulation (DIC) progresses at a different rate in tissue factor-induced and lipopolysaccharide-induced DIC models in rats. Blood Coagulation and Fibrinolysis 14(3): 221-228, 2003

Marked difference in pathophysiology between tissue factor- and lipopolysaccharide-induced disseminated intravascular coagulation models in rats. Critical Care Medicine 30(1): 161-164, 2002

Role of fibrinolysis in tissue-factor-induced disseminated intravascular coagulation in rats - an effect of tranexamic acid. Haematologica 89(6): 757-758, 2004

Inhibition by recombinant hirudins of experimental venous thrombosis and disseminated intravascular coagulation induced by tissue factor in rats. Thrombosis and Haemostasis 63(2): 187-192, 1990

Inhibitory effect of TCV-309, a novel platelet activating factor (PAF) antagonist, on endotoxin-induced disseminated intravascular coagulation in rats: Possible role of PAF in tissue factor generation. Thrombosis Research 70(4): 281-293, 1993

Intravenous extended infusion of recombinant human soluble thrombomodulin prevented tissue factor-induced disseminated intravascular coagulation in rats. American Journal Of Hematology. 45(4): 298-303, 1994

Effect of endothelial cell adhesion molecules on monocyte tissue factor expression Implications for initiation of coagulation in disseminated intravascular coagulation. British Journal of Haematology 117(Suppl. 1): 91, 2002

Relationship between endothelin and the pathophysiology of tissue factor-induced and lipopolysaccharide-induced disseminated intravascular coagulation in rats: a study examining the effect of an endothelin receptor antagonist. Blood Coagulation & Fibrinolysis 15(7): 593-598, 2004

Expression of tissue factor and tissue factor pathway inhibitor in rat lungs with lipopolysaccharide-induced disseminated intravascular coagulation. Laboratory Investigation 77(6): 581-589, 1997

Effect of alcohol on the course of collagenolysis and on certain parameters of disseminated intravascular coagulation and thrombopoiesis in rats with carrageenin induced inflammation. Reumatologia 25(2): 73-81, 1987

Evaluation of several parameters of coagulation in liver cirrhosis: disseminated intravascular coagulation or pseudo-disseminated intravascular coagulation?. Minerva Medica 79(3): 193-198, 1988

Effect of hydrogen sulfide on tissue factor-induced disseminated intravascular coagulation in rabbits. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 27(2): 92-96, 2015